Asthma and obesity are both common conditions, which lead to a substantial public health burden. The obese-asthma phenotype is characterized by poor asthma control, impaired lung function and decreased efficacy of inhaled treatment. However, this phenotype is highly heterogeneous and involves numerous mechanisms, including systemic inflammation and adipokines. A role for microbiota modifications and genetics has been suggested. Obese-asthma patient management currently consists in weight loss and usual anti-asthmatic treatment. New therapeutic options are being evaluated.
Keywords: Adipokines; Asthma; Asthme; Microbiota; Microbiote; Obesity; Obésité; Phenotype.
Copyright © 2019 SPLF. Published by Elsevier Masson SAS. All rights reserved.